Signaling scaffold Shoc2 regulates lymphangiogenesis by suppressing mTORC1-mediated IFN responses

Area of Science:

• Molecular Biology
• Developmental Biology
• Immunology

Background:

• Lymphatic vasculature development is essential for fluid homeostasis and immune function.
• Dysregulation of lymphatic development can cause congenital disorders.
• Molecular mechanisms regulating lymphangiogenesis are not fully understood.

Purpose of the Study:

• To investigate the role of the signaling scaffold protein Shoc2 in lymphangiogenesis.
• To elucidate the molecular mechanisms by which Shoc2 regulates lymphatic development.

Main Methods:

• In vivo and in vitro studies using Shoc2 knockout models.
• Analysis of signaling pathways including ERK1/2 and mTORC1.
• Assessment of mitochondrial function and innate immune responses.

Main Results:

• Shoc2 deficiency leads to severe defects in lymphatic vasculature formation in vivo.
• Loss of Shoc2 induces senescence in lymphatic endothelial cells in vitro.
• Shoc2 regulates ERK1/2 and mTORC1 signaling, impacting mitochondrial respiration and triggering an IRF/IFN-II response.

Conclusions:

• Shoc2 plays a critical role in lymphangiogenesis.
• Shoc2 signaling is essential for maintaining lymphatic endothelial cell function and preventing senescence.
• Disruptions in Shoc2 signaling have implications for Ras-pathway-related congenital disorders.